Lv5
1320 积分 2021-10-15 加入
Minimal residual disease as a target for liquid biopsy in patients with solid tumours
4天前
已完结
Assessment of Minimal/Measurable Residual Disease Testing in Acute Myeloid Leukaemia By Molecular Methods in an Interlaboratory Study
4天前
求助中
Molecular residual disease analysis of adjuvant osimertinib in resected EGFR-mutated stage IB–IIIA non-small-cell lung cancer
8天前
已完结
Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trial
8天前
已完结
Validation and benchmarking of targeted panel sequencing for cancer genomic profiling
8天前
已完结
Correction to: Validation and benchmarking of targeted panel sequencing for cancer genomic profiling
8天前
已完结
Nucleic acid-based reference materials: a “ruler” for precision molecular diagnostics
10天前
已完结
Acceptable performance of blood biomarker tests of amyloid pathology — recommendations from the Global CEO Initiative on Alzheimer’s Disease
14天前
已完结
Minimal residual disease in colorectal cancer. Tumor-informed versus tumor-agnostic approaches: unraveling the optimal strategy
17天前
已完结
Head‐to‐head comparison of genotyping of human papillomavirus by real‐time multiplex PCR assay using type‐specific primers and SPF10‐PCR‐based line probe assay
1个月前
已完结
皖公网安备34019202002308
